Ruthenium(II)–Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs

Colorectal cancer (CRC) is one of the most common malignancies and one of the leading causes of cancer-related death worldwide, urging the need for new and more efficient therapeutic approaches. Ruthenium complexes have emerged as attractive alternatives to traditional platinum-based compounds in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Teixeira-Guedes, Catarina, Brás, Ana Rita, Teixeira, Ricardo G., Valente, Andreia, Preto, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228117/
https://www.ncbi.nlm.nih.gov/pubmed/35745864
http://dx.doi.org/10.3390/pharmaceutics14061293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228117/
https://www.ncbi.nlm.nih.gov/pubmed/35745864
http://dx.doi.org/10.3390/pharmaceutics14061293

Ejemplares similares